COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 58: Line 58:


'''Neurologic Disorders and COVID-19 Team Members'''
'''Neurologic Disorders and COVID-19 Team Members'''
*'''Fahimehalsadat Shojaei, MD'''
*'''Syed Musadiq Ali, MD'''
*'''Niloofarsadaat Eshaghhosseiny'''
*Muhammad Adnan Haider
*Muhammad Adnan Haider
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]]

Revision as of 15:13, 12 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are bold:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and of COVID-19

  • Farima Kahe

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

  • Sara Mohsin
  • Ayesha Farheen Javid
  • Usman Ali akbar
  • Rina Ghorpade
  • Rana Aljebzi (not trained yet)

Radiologic Manifestations of COVID-19 Team Members


Other Team Members